JNJ vs PFE
JNJ and PFE side by side — valuation & fundamentals (public data).
Key statistics
| Metric | JNJJohnson & Johnson | PFEPfizer Inc. |
|---|---|---|
| Market cap | $609.06B | $142.77B |
| P/E (TTM) | 29.3 | 19.1 |
| P/B | 7.50 | 1.58 |
| P/S | 6.5x | 2.3x |
| Dividend yield | 2.03% | 6.84% |
| Revenue | $96.36B(TTM) | $63.31B(TTM) |
| Revenue growth (YoY) | 6.0% | -1.6% |
| Net income | $21.04B(TTM) | $7.49B(TTM) |
| Earnings growth (YoY) | 90.6% | -3.2% |
| EPS, diluted | $8.63(TTM) | $1.31(TTM) |
| EBIT margin | 22.9% | 16.3% |
| ROE | 33.0% | 8.6% |
| ROIC | 16.8% | 6.7% |
| Piotroski F | 5/9 | — |
| 1y total return | +58.5% | +8.8% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: JNJ vs PFE
| 지표 | JNJ | PFE |
|---|---|---|
| 최종 가치 | $31.1K | $13.4K |
| 총수익률 | +210.9% | +33.5% |
| CAGR | +11.6% | +2.8% |
| 변동성 | 18.5% | 23.9% |
| 샤프 | 0.48 | 0.08 |
| 소르티노 | 0.68 | 0.11 |
| 최대 낙폭 | -27.4% | -59.0% |
공통 거래일 2600일 기준, 2016-03-15 → 2026-07-17 · 무위험수익률 3.85% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)